Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.96
+0.16 (0.59%)
Aug 21, 2026, 2:55 PM EDT - Market open
Pfizer Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 159,334 | 141,574 | 150,345 | 162,560 | 287,626 | 331,440 | |
Market Cap Growth | 10.68% | -5.83% | -7.51% | -43.48% | -13.22% | 61.99% |
Enterprise Value | 211,110 | 188,821 | 208,609 | 182,781 | 288,752 | 341,892 |
Last Close Price | 27.79 | 23.68 | 23.53 | 24.06 | 40.96 | 45.72 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.53 | 18.22 | 18.72 | 76.72 | 9.17 | 15.08 |
Forward PE | 10.03 | 8.54 | 9.91 | 19.25 | 10.82 | 10.64 |
PS Ratio | 2.51 | 2.26 | 2.36 | 2.73 | 2.84 | 4.08 |
PB Ratio | 1.86 | 1.63 | 1.70 | 1.82 | 3.00 | 4.28 |
P/TBV Ratio | - | - | - | - | 314.00 | 116.42 |
P/FCF Ratio | 14.57 | 15.60 | 15.29 | 33.92 | 11.05 | 11.10 |
P/OCF Ratio | 11.94 | 12.10 | 11.80 | 18.68 | 9.83 | 10.17 |
PEG Ratio | - | 29.47 | 1.27 | 1.32 | 5.15 | 1.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.33 | 3.02 | 3.28 | 3.07 | 2.85 | 4.21 |
EV/EBITDA Ratio | 8.35 | 7.34 | 9.25 | 14.54 | 6.44 | 10.66 |
EV/EBIT Ratio | 11.24 | 9.85 | 13.41 | 28.94 | 7.25 | 12.67 |
EV/FCF Ratio | 19.28 | 20.81 | 21.21 | 38.14 | 11.09 | 11.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.74 | 0.78 | 0.76 | 0.84 | 0.41 | 0.53 |
Debt / EBITDA Ratio | 2.41 | 2.54 | 2.84 | 5.44 | 0.85 | 1.26 |
Debt / FCF Ratio | 5.78 | 7.45 | 6.86 | 15.72 | 1.51 | 1.39 |
Net Debt / Equity Ratio | 0.61 | 0.62 | 0.53 | 0.70 | 0.17 | 0.13 |
Net Debt / EBITDA Ratio | 2.04 | 2.10 | 2.08 | 4.98 | 0.37 | 0.32 |
Net Debt / FCF Ratio | 4.71 | 5.96 | 4.77 | 13.07 | 0.64 | 0.35 |
Asset Turnover | 0.31 | 0.30 | 0.29 | 0.28 | 0.53 | 0.48 |
Inventory Turnover | 1.49 | 1.41 | 1.63 | 2.50 | 3.78 | 3.59 |
Quick Ratio | 0.85 | 0.80 | 0.82 | 0.59 | 0.88 | 1.10 |
Current Ratio | 1.27 | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 |
Return on Equity (ROE) | 5.01% | 8.89% | 9.06% | 2.35% | 36.22% | 31.87% |
Return on Assets (ROA) | 5.78% | 5.68% | 4.42% | 1.86% | 13.15% | 10.05% |
Return on Invested Capital (ROIC) | 13.49% | 13.87% | 10.83% | 4.78% | 35.96% | 27.65% |
Return on Capital Employed (ROCE) | 11.20% | 11.20% | 9.10% | 3.50% | 25.70% | 19.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.71% | 5.49% | 5.34% | 1.30% | 10.91% | 6.63% |
FCF Yield | 6.86% | 6.41% | 6.54% | 2.95% | 9.05% | 9.01% |
Dividend Yield | 6.15% | 7.26% | 7.14% | 6.82% | 3.91% | 3.41% |
Payout Ratio | 226.35% | 125.74% | 118.44% | 436.39% | 28.63% | 39.72% |
Buyback Yield / Dilution | -0.34% | -0.23% | 0.16% | 0.42% | -0.44% | -1.35% |
Total Shareholder Return | 5.78% | 7.04% | 7.30% | 7.24% | 3.47% | 2.06% |